162 related articles for article (PubMed ID: 30926764)
1. Endothelial cells secreted endothelin-1 augments diabetic nephropathy via inducing extracellular matrix accumulation of mesangial cells in ETBR
Zou HH; Wang L; Zheng XX; Xu GS; Shen Y
Aging (Albany NY); 2019 Mar; 11(6):1804-1820. PubMed ID: 30926764
[TBL] [Abstract][Full Text] [Related]
2. Repression of microRNA-382 inhibits glomerular mesangial cell proliferation and extracellular matrix accumulation via FoxO1 in mice with diabetic nephropathy.
Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhuang J; Zhang ZF; Shan Q; Li MQ; Hu B; Sun CH; Wu DM; Lu J; Zheng YL
Cell Prolif; 2018 Oct; 51(5):e12462. PubMed ID: 29701296
[TBL] [Abstract][Full Text] [Related]
3. circLRP6 regulates high glucose-induced proliferation, oxidative stress, ECM accumulation, and inflammation in mesangial cells.
Chen B; Li Y; Liu Y; Xu Z
J Cell Physiol; 2019 Nov; 234(11):21249-21259. PubMed ID: 31087368
[TBL] [Abstract][Full Text] [Related]
4. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
[TBL] [Abstract][Full Text] [Related]
5. Danggui buxue tang inhibited mesangial cell proliferation and extracellular matrix accumulation through GAS5/NF-κB pathway.
Zhang R; Han X; Huang T; Wang X
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31481528
[TBL] [Abstract][Full Text] [Related]
6. Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis.
Lenoir O; Milon M; Virsolvy A; Hénique C; Schmitt A; Massé JM; Kotelevtsev Y; Yanagisawa M; Webb DJ; Richard S; Tharaux PL
J Am Soc Nephrol; 2014 May; 25(5):1050-62. PubMed ID: 24722437
[TBL] [Abstract][Full Text] [Related]
7. Liquiritigenin attenuates high glucose-induced mesangial matrix accumulation, oxidative stress, and inflammation by suppression of the NF-κB and NLRP3 inflammasome pathways.
Zhu X; Shi J; Li H
Biomed Pharmacother; 2018 Oct; 106():976-982. PubMed ID: 30119269
[TBL] [Abstract][Full Text] [Related]
8. Activation of RhoA/ROCK regulates NF-κB signaling pathway in experimental diabetic nephropathy.
Xie X; Peng J; Chang X; Huang K; Huang J; Wang S; Shen X; Liu P; Huang H
Mol Cell Endocrinol; 2013 Apr; 369(1-2):86-97. PubMed ID: 23376009
[TBL] [Abstract][Full Text] [Related]
9. Tetrahydrobiopterin contributes to the proliferation of mesangial cells and accumulation of extracellular matrix in early-stage diabetic nephropathy.
Wang J; Yang Q; Nie Y; Guo H; Zhang F; Zhou X; Yin X
J Pharm Pharmacol; 2017 Feb; 69(2):182-190. PubMed ID: 28033650
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of ANGPTL-4 inhibits inflammatory response and extracellular matrix accumulation in glomerular mesangial cells cultured under high glucose condition.
Qin L; Zhang R; Yang S; Chen F; Shi J
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3368-3373. PubMed ID: 31387395
[TBL] [Abstract][Full Text] [Related]
11. Effects of microRNA-370 on mesangial cell proliferation and extracellular matrix accumulation by binding to canopy 1 in a rat model of diabetic nephropathy.
Yu FN; Hu ML; Wang XF; Li XP; Zhang BH; Lu XQ; Wang RQ
J Cell Physiol; 2019 May; 234(5):6898-6907. PubMed ID: 30317577
[TBL] [Abstract][Full Text] [Related]
12. Nobiletin suppresses high-glucose-induced inflammation and ECM accumulation in human mesangial cells through STAT3/NF-κB pathway.
Liu Z; Han Y; Zhao F; Zhao Z; Tian J; Jia K
J Cell Biochem; 2019 Mar; 120(3):3467-3473. PubMed ID: 30499124
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA circRNA_15698 aggravates the extracellular matrix of diabetic nephropathy mesangial cells via miR-185/TGF-β1.
Hu W; Han Q; Zhao L; Wang L
J Cell Physiol; 2019 Feb; 234(2):1469-1476. PubMed ID: 30054916
[TBL] [Abstract][Full Text] [Related]
14. Aryl Hydrocarbon Receptor Deficiency Attenuates Oxidative Stress-Related Mesangial Cell Activation and Macrophage Infiltration and Extracellular Matrix Accumulation in Diabetic Nephropathy.
Lee WJ; Liu SH; Chiang CK; Lin SY; Liang KW; Chen CH; Tien HR; Chen PH; Wu JP; Tsai YC; Lai DW; Chang YC; Sheu WH; Sheu ML
Antioxid Redox Signal; 2016 Feb; 24(4):217-231. PubMed ID: 26415004
[TBL] [Abstract][Full Text] [Related]
15. Vasopressin stimulates the production of extracellular matrix by cultured rat mesangial cells.
Tahara A; Tsukada J; Tomura Y; Suzuki T; Yatsu T; Shibasaki M
Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):586-93. PubMed ID: 18177476
[TBL] [Abstract][Full Text] [Related]
16. SND p102 promotes extracellular matrix accumulation and cell proliferation in rat glomerular mesangial cells via the AT1R/ERK/Smad3 pathway.
Xu JL; Gan XX; Ni J; Shao DC; Shen Y; Miao NJ; Xu D; Zhou L; Zhang W; Lu LM
Acta Pharmacol Sin; 2018 Sep; 39(9):1513-1521. PubMed ID: 30150789
[TBL] [Abstract][Full Text] [Related]
17. Diabetic endothelin B receptor-deficient rats develop severe hypertension and progressive renal failure.
Pfab T; Thöne-Reineke C; Theilig F; Lange I; Witt H; Maser-Gluth C; Bader M; Stasch JP; Ruiz P; Bachmann S; Yanagisawa M; Hocher B
J Am Soc Nephrol; 2006 Apr; 17(4):1082-9. PubMed ID: 16495378
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA TUG1 alleviates extracellular matrix accumulation via mediating microRNA-377 targeting of PPARγ in diabetic nephropathy.
Duan LJ; Ding M; Hou LJ; Cui YT; Li CJ; Yu DM
Biochem Biophys Res Commun; 2017 Mar; 484(3):598-604. PubMed ID: 28137588
[TBL] [Abstract][Full Text] [Related]
19. Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model.
Masuda K; Tanabe K; Ujike H; Hinamoto N; Miyake H; Tanimura S; Sugiyama H; Sato Y; Maeshima Y; Wada J
PLoS One; 2018; 13(4):e0195779. PubMed ID: 29641565
[TBL] [Abstract][Full Text] [Related]
20. Aliskiren, exendin-4, and insulin: their impact on endothelin receptor subtype(s) regulation/binding in type 1 diabetic rat hearts.
Al Lafi SM; Artinian SB; Boutary SS; Zwainy NS; Bitar KM; Bikhazi AB
Can J Physiol Pharmacol; 2013 Oct; 91(10):830-8. PubMed ID: 24144054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
